Latest news with #Church&Dwight
Yahoo
01-08-2025
- Business
- Yahoo
Church & Dwight's (NYSE:CHD) Q2 Sales Top Estimates
Household products company Church & Dwight (NYSE:CHD) reported revenue ahead of Wall Street's expectations in Q2 CY2025, but sales were flat year on year at $1.51 billion. The company expects next quarter's revenue to be around $1.53 billion, close to analysts' estimates. Its non-GAAP profit of $0.94 per share was 9.7% above analysts' consensus estimates. Is now the time to buy Church & Dwight? Find out in our full research report. Church & Dwight (CHD) Q2 CY2025 Highlights: Revenue: $1.51 billion vs analyst estimates of $1.48 billion (flat year on year, 1.6% beat) Adjusted EPS: $0.94 vs analyst estimates of $0.86 (9.7% beat) Adjusted EBITDA: $297.6 million vs analyst estimates of $349.9 million (19.8% margin, 14.9% miss) Revenue Guidance for Q3 CY2025 is $1.53 billion at the midpoint, roughly in line with what analysts were expecting Adjusted EPS guidance for Q3 CY2025 is $0.72 at the midpoint, below analyst estimates of $0.86 Operating Margin: 17.4%, down from 22.3% in the same quarter last year Free Cash Flow Margin: 13.8%, similar to the same quarter last year Organic Revenue was flat year on year (4.7% in the same quarter last year) Market Capitalization: $23.09 billion Rick Dierker, Chief Executive Officer, commented, 'Our brands continue to perform well in this dynamic environment. We continue to drive both dollar and volume share gains across most of our brands. Our balanced portfolio of value and premium products and our relentless focus on innovation continues to position us well for the future. Importantly, we began to see category growth levels improve sequentially through the second quarter, which provides further confidence in our full year outlook. Company Overview Best known for its Arm & Hammer baking soda, Church & Dwight (NYSE:CHD) is a household and personal care products company with a vast portfolio that spans laundry detergent to toothbrushes to hair removal creams. Revenue Growth Reviewing a company's long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. With $6.07 billion in revenue over the past 12 months, Church & Dwight carries some recognizable products but is a mid-sized consumer staples company. Its size could bring disadvantages compared to larger competitors benefiting from better brand awareness and economies of scale. As you can see below, Church & Dwight's sales grew at a tepid 4.6% compounded annual growth rate over the last three years, but to its credit, consumers bought more of its products. This quarter, Church & Dwight's $1.51 billion of revenue was flat year on year but beat Wall Street's estimates by 1.6%. Company management is currently guiding for a 1.5% year-on-year increase in sales next quarter. Looking further ahead, sell-side analysts expect revenue to grow 2.6% over the next 12 months, a slight deceleration versus the last three years. This projection is underwhelming and indicates its products will see some demand headwinds. Software is eating the world and there is virtually no industry left that has been untouched by it. That drives increasing demand for tools helping software developers do their jobs, whether it be monitoring critical cloud infrastructure, integrating audio and video functionality, or ensuring smooth content streaming. Click here to access a free report on our 3 favorite stocks to play this generational megatrend. Organic Revenue Growth When analyzing revenue growth, we care most about organic revenue growth. This metric captures a business's performance excluding one-time events such as mergers, acquisitions, and divestitures as well as foreign currency fluctuations. The demand for Church & Dwight's products has generally risen over the last two years but lagged behind the broader sector. On average, the company's organic sales have grown by 3.4% year on year. In the latest quarter, Church & Dwight's year on year organic sales were flat. This was a meaningful deceleration from its historical levels. We'll be watching closely to see if Church & Dwight can reaccelerate growth. Key Takeaways from Church & Dwight's Q2 Results It was encouraging to see Church & Dwight beat analysts' revenue expectations this quarter. We were also happy its EPS outperformed Wall Street's estimates. On the other hand, its EBITDA missed and its EPS guidance for next quarter fell short of Wall Street's estimates. Overall, this was a mixed quarter. The stock remained flat at $93.58 immediately after reporting. Church & Dwight didn't show it's best hand this quarter, but does that create an opportunity to buy the stock right now? What happened in the latest quarter matters, but not as much as longer-term business quality and valuation, when deciding whether to invest in this stock. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
10-07-2025
- Business
- Business Insider
Church & Dwight (CHD) Receives a Buy from RBC Capital
RBC Capital analyst Nik Modi maintained a Buy rating on Church & Dwight on July 8 and set a price target of $114.00. The company's shares closed yesterday at $98.39. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Modi is a 3-star analyst with an average return of 1.2% and a 51.98% success rate. Modi covers the Consumer Defensive sector, focusing on stocks such as Constellation Brands, Procter & Gamble, and Clorox. Currently, the analyst consensus on Church & Dwight is a Moderate Buy with an average price target of $105.21, a 6.93% upside from current levels. In a report released yesterday, Wells Fargo also maintained a Buy rating on the stock with a $108.00 price target. The company has a one-year high of $116.46 and a one-year low of $90.99. Currently, Church & Dwight has an average volume of 2.4M. Based on the recent corporate insider activity of 90 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of CHD in relation to earlier this year. Last month, Hooker Carlen, the EVP & CCO of CHD sold 6,380.00 shares for a total of $627,154.00.
Yahoo
27-06-2025
- Business
- Yahoo
3 Out-of-Favor Stocks in Hot Water
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives. Price charts only tell part of the story. Our team at StockStory evaluates each company's underlying fundamentals to separate temporary setbacks from structural declines. That said, here are three stocks where the outlook is warranted and some alternatives with better fundamentals. One-Month Return: -3% Best known for its Arm & Hammer baking soda, Church & Dwight (NYSE:CHD) is a household and personal care products company with a vast portfolio that spans laundry detergent to toothbrushes to hair removal creams. Why Is CHD Not Exciting? Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth Estimated sales growth of 1% for the next 12 months implies demand will slow from its three-year trend Expenses have increased as a percentage of revenue over the last year as its operating margin fell by 4.9 percentage points Church & Dwight's stock price of $94.97 implies a valuation ratio of 25.2x forward P/E. If you're considering CHD for your portfolio, see our FREE research report to learn more. One-Month Return: -3.8% Best known for its aluminum foil, Reynolds (NASDAQ:REYN) is a household products company whose products focus on food storage, cooking, and waste. Why Do We Pass on REYN? Falling unit sales over the past two years show it's struggled to move its products and had to rely on price increases Forecasted revenue decline of 1.4% for the upcoming 12 months implies demand will fall off a cliff Free cash flow margin dropped by 6.1 percentage points over the last year, implying the company became more capital intensive as competition picked up Reynolds is trading at $21.49 per share, or 13x forward P/E. Read our free research report to see why you should think twice about including REYN in your portfolio, it's free. One-Month Return: +2.4% Launching the careers of legendary artists like Frank Sinatra, Warner Music Group (NASDAQ:WMG) is a music company managing a diverse portfolio of artists, recordings, and music publishing services worldwide. Why Are We Hesitant About WMG? 4.4% annual revenue growth over the last two years was slower than its consumer discretionary peers Estimated sales growth of 3.7% for the next 12 months is soft and implies weaker demand Low returns on capital reflect management's struggle to allocate funds effectively At $26.80 per share, Warner Music Group trades at 9.2x forward EV-to-EBITDA. Dive into our free research report to see why there are better opportunities than WMG. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
10-06-2025
- Health
- USA Today
Fungi concerns prompt recall for certain Orajel, Zicam products
Fungi concerns prompt recall for certain Orajel, Zicam products Church & Dwight said this recall is limited exclusively to certain Zicam and Orajel swab products. Show Caption Hide Caption How to brush your teeth better You can get cleaner teeth with this brushing routine. ProblemSolved, USA TODAY The manufacturer of Orajel teething swabs and Zicam cold relief products has voluntarily issued a nationwide recall due to possible fungal contamination, according to a notice posted by the Food and Drug Administration (FDA). Church & Dwight Co., Inc. announced the recall on Friday, June 6, for certain Zicam Cold Remedy Nasal Swabs, Zicam Nasal AllClear Swabs and Orajel Baby Teething Swabs. The affected products, which were distributed nationwide in the U.S. and Puerto Rico, may contain microbial contamination, identified as fungi, in the cotton swab components. Swabs containing fungi can potentially present "significant risk to the health and safety of consumers," including serious and life-threatening blood infections in consumers whose nasal cavity's mucous membrane lining may be compromised due to inflammation and mechanical injuries, according to the FDA recall notice. The health risks of using the recalled products are highest, and potentially severe or life-threatening, among children and people with compromised immune systems or other underlying medical conditions, according to the notice. What are the recalled Church & Dwight products? According to Church & Dwight, the recalled products include: Zicam Cold Remedy Nasal Swabs, with UPC 732216301205, all lots: A zinc-free, homeopathic cold remedy swab designed to shorten the duration of the common cold. A zinc-free, homeopathic cold remedy swab designed to shorten the duration of the common cold. Zicam Nasal AllClear Swabs, with UPC 732216301656, all lots: A nasal cleansing swab product that was discontinued in December 2024. A nasal cleansing swab product that was discontinued in December 2024. Orajel Baby Teething Swabs, with UPC 310310400002, all lots: Pre-moistened swabs designed to soothe teething discomfort in infants and toddlers. What should consumers do? Individuals who have bought any of the recalled Church & Dwight products should stop using them immediately, according to the consumer goods company. Consumers can visit or call its consumer relations team at (800) 981-4710 for a full refund. Any additional questions can also be directed to its consumer relations team Monday through Friday, 9 a.m. – 5 p.m. ET. Adverse reactions or quality problems experienced while using the recalled products can be reported to the FDA's MedWatch Adverse Event Reporting program online, by regular mail or by fax. Individuals can complete and submit the report online. According to Church & Dwight, this recall is limited exclusively to Zicam and Orajel swab products. All other Zicam and Orajel products, including Zicam RapidMelts, are not affected by this recall.
Yahoo
08-06-2025
- Health
- Yahoo
Baby swabs and nasal swabs recalled for possible fungus in swab parts
Swabs for teething babies and adult noses have been recalled because they might have a microbial contamination 'identified as fungi in cotton swab components.' That's what manufacturer Church & Dwight said in its notice announcing the recall of Orajel Baby Teething Swabs, Zicam Cold Remedy Nasal Swabs and Zicam Nasal AllClear Swabs from stores across the United States, including Puerto Rico. The lots and expiration dates involved? All. READ MORE: Recalled UTI drug could have deadly microbial contamination Swabs with a microbial contamination can cause 'serious and life-threatening blood infections in users whose nasal mucosa may be compromised due to inflammation and mechanical injurie,' the recall notice states. 'The risk is highest (potentially severe or life-threatening) among children and individuals with compromised immune systems or other underlying medical conditions.' ▪ Zicam Cold Remedy Nasal Swabs carry UPC No. 732216301205. ▪ Zicam Nasal AllClear Swabs, which were discontinued in December, carry UPC No. 732216301656. ▪ Orajel baby swabs carry UPC No. 310310400002. If you have the swabs, throw them in the trash or, for a refund, reach out go Church & Dwight either online or by calling 800-981-4710. Questions can be directed to that phone number, 9 a.m. to 5 p.m., Monday through Friday. If you think you or your baby is having a medical issue caused by these swabs, go see a medical professional. Then, notify the FDA's MedWatch Adverse Event Program, either by filling out a form online or by requesting a reporting form at 800-332-1088. Then, third, call Church & Dwight.
